BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6153199)

  • 1. The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens.
    Biddison WE; Ward FE; Shearer GM; Shaw S
    J Immunol; 1980 Feb; 124(2):548-52. PubMed ID: 6153199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in HLA antigen recognition by human influenza virus-immune cytotoxic T cells.
    Biddison WE; Shaw S
    J Immunol; 1979 May; 122(5):1705-9. PubMed ID: 87440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules.
    Biddison WE; Krangel MS; Strominger JL; Ward FE; Shearer GM; Shaw S
    Hum Immunol; 1980 Oct; 1(3):225-32. PubMed ID: 6167549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytotoxic T cell responses to trinitrophenyl hapten and influenza virus. Diversity of restriction antigens and specificity of HLA-linked genetic regulation.
    Biddison WE; Payne SM; Shearer GM; Shaw S
    J Exp Med; 1980 Aug; 152(2 Pt 2):204s-217s. PubMed ID: 6157766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of immunologically and biochemically distinct HLA-A2 antigens.
    Biddison WE; Kostyu DD; Strominger JL; Krangel MS
    J Immunol; 1982 Aug; 129(2):730-4. PubMed ID: 6177780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza virus-specific cytotoxic T cells are restricted by multiple HLA-A3-related self antigens: evidence for recognition of distinct self structures in conjunction with different foreign antigens.
    Biddison WE; Shearer GM; Shaw S
    J Immunol; 1981 Dec; 127(6):2231-5. PubMed ID: 6975312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus specificity of human influenza virus-immune cytotoxic T cells.
    Biddison WE; Shaw S; Nelson DL
    J Immunol; 1979 Feb; 122(2):660-4. PubMed ID: 84032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies.
    McMichael AJ; Parham P; Brodsky FM; Pilch JR
    J Exp Med; 1980 Aug; 152(2 Pt 2):195s-203s. PubMed ID: 6967937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may recognize different self determinants.
    Goulmy E; van Leeuwen A; Blokland E; van Rood JJ; Biddison WE
    J Exp Med; 1982 May; 155(5):1567-72. PubMed ID: 6175722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloned lines of human cytotoxic T lymphocytes with specificity for influenza virus.
    Fleischer B
    J Immunol; 1982 Oct; 129(4):1731-5. PubMed ID: 6180020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.
    Kannagi M; Sugamura K; Sato H; Okochi K; Uchino H; Hinuma Y
    J Immunol; 1983 Jun; 130(6):2942-6. PubMed ID: 6189906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two subgroups of HLA Bw44 defined by cell-mediated lympholysis that differ in Bw44 expression on platelets and in patterns of genetic linkage disequilibrium.
    Tekolf WA; Biddison WE; Aster RD; Shaw S
    J Immunol; 1982 Oct; 129(4):1474-8. PubMed ID: 6180011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
    Nelson DL; Biddison WE; Shaw S
    J Immunol; 1983 Jun; 130(6):2629-34. PubMed ID: 6189897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA restriction of secondary mumps-specific cytotoxic T lymphocytes.
    Kress HG; Kreth HW
    J Immunol; 1982 Aug; 129(2):844-9. PubMed ID: 6177787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte recognition of HLA-A/B antigens introduced into EL4 cells by cell-liposome fusion.
    Engelhard VH; Powers GA; Moore LC; Holterman MJ; Correa-Freire MC
    J Immunol; 1984 Jan; 132(1):76-80. PubMed ID: 6197461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of mouse cytotoxic T lymphocytes stimulated with either HLA-A and -B or HLA-DR antigens reconstituted into phospholipid vesicles.
    Engelhard VH; Kaufman JF; Strominger JL; Burakoff SJ
    J Exp Med; 1980 Aug; 152(2 Pt 2):54s-64s. PubMed ID: 6157770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
    Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
    Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.